We show that these observations may extend to lung carcinomas, which show increased MAP17 expression compared to that of normal lung tissue, especially in lung adenocarcinomas, the histological subtype with the highest MAP17 levels. This evidence concerns the gene PDZK1IP1 and lung carcinoma.